City Therapeutics Files for US IPO
City Therapeutics filed for a US initial public offering on Thursday as a wave of biotech firms look to tap the fall market. The RNA-based drug developer plans to list on the Nasdaq under the symbol CTY.
Xurve View
Insights:
Xurve View
City Therapeutics filed for an initial public offering in the United States on Thursday, aiming to list on the Nasdaq under the symbol CTY. The biotech firm joins a growing wave of drug developers testing public markets during the fall window. The offering is managed by underwriters including GOLDMAN SACHS GROUP INC, JEFFERIES FINANCIAL GROUP IN, STIFEL FINANCIAL CORP, and OPPENHEIMER HOLDINGS-CL A.
